Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies

Smita Vaidya, David Partlow, Titus Barnes, Phillip E. Thomas, K.K. Gugliuzza

Clinical Transplantation · 2006 · 16 citations · 10 references

Abstract

These data showed that patients positive for sCD30 contents are at high risk for the development of DSA and AR post-transplant regardless of their pre-transplant PRA.

References

10